期刊文献+

壮医药线点灸疗法对去卵巢家兔性激素的影响 被引量:16

Effects of medicated thread moxibustion of Zhuang medicine on sex hormone in ovariectomized rabbits
原文传递
导出
摘要 目的:探讨壮医药线点灸疗法治疗围绝经期综合征的作用机制。方法:将30只家兔随机分为正常组、模型组、药线组、空线组和假手术组,每组6只。采用摘除卵巢去势建立围绝经期综合征模型。造模后药线组采用壮医药线点灸"脐周穴""下关元""肾俞""脾俞"等穴,每日1次,共治疗4周;空线组采用空线点灸与药线组相同穴位,其余各组不做干预处理,分别于治疗前后观察各组性激素的变化。结果:去势后血清雌二醇(E_2)水平模型组为(308.33±12.58)pmol/L、空线组为(303.43±10.57)pmol/L、药线组为(304.96±13.85)pmol/L,较正常组的(478.09±12.23)pmol/L、假手术组的(488.05±11.45)pmol/L下降(均P<0.01)。治疗后,E_2水平药线组为(338.92±11.23)pmol/L,有所上升(P<0.01),高于模型组的(300.53±13.68)pmol/L、空线组的(309.74±13.59)pmol/L(均P<0.01);药线组卵泡刺激素(FSH)为(58.90±5.29)U/L、黄体生成激素(LH)为(64.65±5.23)U/L,水平低于模型组的(65.41±5.19)U/L、(71.85±5.30)U/L(均P<0.05)。结论:壮医药线点灸疗法可提高去势家兔血清E_2水平及降低FSH、LH水平,这可能是其治疗围绝经期综合征的作用机制之一。 Objective To explore the mechanism of medicated thread moxibustion of Zhuang medicine (MTMZ) in treating perimenopausal period syndrome. Methods Thirty rabbits were randomly divided into a normal group, a model group, a medicated thread group, a no-medicated thread group and a sham operation group, 6 cases in each group. The model of perimenopausal period syndrome was established by ovariectomizing the ovary. The medicated thread group was treated with MTMZ at "Qizhou" acupoint (Extra), "Xiaguanyuan"(Extra), "Shenshu" (BL 23) and "Pishu" (BL 20), etc. , once each day for 4 weeks. The no medicated thread group was treated with no-medicated thread moxibustion at the same acupoints, and there is no treatment in the other groups. The changes of hormone level in each group before and after the treatment were observed. Results After ovarieetomizing the ovary,the serum estradiol (Ez) in the model group[(308.33 ±12.58) pmol/L], the medicated thread group [(304.96 ± 13.85)pmol/L]and the no-medicated thread group[(303.43± 10.57)pmol/L] were lower than that in the normal group [(478.09± 12.23)pmol/L]and the sham operation group [(488.05±11.45)pmol/L] (all P〈0. 01). After treatment, the E2 level in medicated thread group [ (338.92 ± 11.23)pmol/L] was higher than before (P〈0.01) and that in the model group [(300.53±13.68)pmol/L] and the no-medicated thread group [(309.74±13.59)pmol/L] (both P〈0.01), and the serum follicle stimulating hormone [FSH, (58.90 ± 5.29)U/L] and luteinizing hormone [LH, (64.65±5.23)U/L] were lower than those in the model group [(65.41±5.19)U/L], [(71.85±5.30)U/L] (both P〈0.05). Conclusion MTMZ can increase the serum E2 and reduce the serum FSH and LH in ovariectomized rabbits, and this may be one of the mechanisms of MTMZ for treatment of perimenopausal period syndrome.
出处 《中国针灸》 CAS CSCD 北大核心 2011年第2期145-148,共4页 Chinese Acupuncture & Moxibustion
基金 广西自然科学基金资助项目:桂科自0832166
关键词 壮医药线点灸疗法 性激素 雌二醇 卵泡刺激素 黄体生成素 模型 家兔 Medicated Thread Moxibustion of Zhuang Medicine (MTMZ) Sex Hormone, E2, FSH, LH Model, Rabbit
  • 相关文献

参考文献10

二级参考文献23

  • 1闫琳丽.围绝经期卵巢功能及老化机制的研究[J].国外医学(妇产科学分册),1996,23(5):262-265. 被引量:12
  • 2赵更力,鲍月琴,渠川琰,王向群.更年期妇女抑郁症状的发生情况及其影响因素[J].中华妇产科杂志,1996,31(10):614-616. 被引量:81
  • 3Opatrny L,Dell'Aniello S,Asseuline S,et al.Hormone replacement therapy use and variations in the risk of breast cancer[J].An International Journal of Obstetrics and Gynaccolagy,2008,115(2):169 -75.
  • 4Rosenberg L U,Magnussen C,Lindstrom E,et al.Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer:a case-control study[J].Breast Cancer Research,2006,8 (1):R11.
  • 5Stanford J L,Weiss N S,Voigt L F,et al.Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women[J].The journal of the American medical association,1995,274 (2):137-42.
  • 6Ross R K,Paganini-Hill A,Wan P C,et al.Effect of hormone replacement therapy on breast cancer risk:estrogen versus estrogen plus progestin[J].Journal of the National Cancer Institute,2000,92(4):328 -32.
  • 7Corrao G,Zambonl A,Conti V,et al.Menopause hormone replacement therapy and cancer risk:an Italian record linkage investigation[J].Annals of Ontology,2008,19 (1):150-5.
  • 8Espié M,Daures J P,Chevallier T,et al.Breast cancer incidence and hormone replacement therapy:results from the MISSION study,prospective phase[J].Gynecological Endocrinology,2007,23(7):391 -7.
  • 9Nielsen N R,Gronaebaek M.Interactions between intakes of alcohol and postmenopausal hormones on risk of breast cancer[J].International journal of cancer,2008,122 (5):1109-13.
  • 10Fournier A,Berrino F,Riboli E,et al.Breast cancer risk in relation to different types of hormone replacement therapy in the E3NEPIC cohort[J].International journal of cancer,2005,114(3):448-54.

共引文献157

同被引文献317

引证文献16

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部